Methotrexat Gry

Methotrexate, the active ingredient in Methotrexat Gry, is an antimetabolite (folate antagonist) presented as a sterile injectable solution for intramuscular, intravenous, or intrathecal use. It is employed to treat autoimmune disorders and certain malignancies in adults and children.

GNH USA supplies Methotrexat Gry as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide, adhering to EU GMP standards and providing reliable global distribution.

Methotrexat Gry is used in diseases where folate metabolism is a therapeutic target, primarily autoimmune and oncologic conditions.

Rheumatoid arthritis: reduces joint inflammation and slows disease progression. Psoriasis: diminishes skin lesions and plaque formation. Acute lymphoblastic leukemia: interferes with malignant cell proliferation. Osteosarcoma: inhibits tumor growth and metastasis. Gestational trophoblastic disease: promotes resolution of trophoblastic tissue.

Methotrexat Gry may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting. - Fatigue or malaise. - Oral mucosal ulceration. - Mild cytopenias (e.g., reduced white blood cells).

Serious or Rare Side Effects: - Hepatotoxicity, including elevated liver enzymes and fibrosis. - Pulmonary toxicity such as interstitial pneumonitis. - Severe bone marrow suppression leading to pancytopenia. - Acute renal failure. - Anaphylactic or severe hypersensitivity reactions.

When prescribing Methotrexat Gry, clinicians should observe several safety measures to minimize risk.

Renal function: evaluate baseline creatinine and adjust dose as needed. Hepatic function: monitor transaminases regularly. Hematologic monitoring: perform complete blood counts before and during therapy. Pregnancy: contraindicated; ensure effective contraception. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexat Gry can interact with other medicines, altering its efficacy or toxicity.

Major Interactions (Avoid): - NSAIDs: may increase methotrexate toxicity by reducing renal clearance. - Penicillins (e.g., ampicillin): can decrease renal elimination leading to higher levels. - Live vaccines: risk of severe infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Sulfonamides: additive bone marrow suppression. - Proton pump inhibitors: may affect renal excretion. - Alcohol: potentiates hepatotoxicity.